{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-043754","form_type":"8-K","ticker":"ZVSA","cik":"0001859007","company_name":"ZyVersa Therapeutics, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.108434+00:00","generated_at":"2026-05-30T04:49:49.046393+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ZyVersa raises ~$1.7M via warrant exercise inducement at $2.06/share","bullets":["Existing warrant holders exercise at reduced price of $2.06/share; gross proceeds ~$1.7M.","Company issues new Series A-2 warrants for 200% of exercised shares, exercise price $2.06, 5-year term.","Engaged A.G.P./Alliance Global Partners as financial advisor; cash fee $110,000 plus $10k expenses.","Net proceeds for working capital and general corporate purposes.","Company to file resale registration statement for new warrant shares by Dec 20, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-043754","json":"https://secwatch.observer/filing/0001493152-24-043754.json","markdown":"https://secwatch.observer/filing/0001493152-24-043754.md","text":"https://secwatch.observer/filing/0001493152-24-043754.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224043754/0001493152-24-043754-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859007/000149315224043754/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:49:49.046393+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}